CN Patent

CN102048734A — 药物组合物

Assigned to Sumitomo Pharma Co Ltd · Expires 2011-05-11 · 15y expired

What this patent protects

本发明涉及药物组合物。本发明涉及一种口服给药制剂，该制剂含有：预糊化淀粉，其含有通式(1)所示的N-[4-[4-(1，2-苯并异噻唑-3-基)-1-哌嗪基]-(2R，3R)-2，3-四亚甲基-丁基]-(1’R，2’S，3’R，4’S)-2，3-双环[2，2，1]庚烷二酰亚胺·盐酸盐(lurasidone)作为活性成分；水溶性赋型剂；水溶性聚合物粘合剂，所述制剂具有恒定的溶出特性，即使其活性成分的含量发生变化时也是如此。

USPTO Abstract

本发明涉及药物组合物。本发明涉及一种口服给药制剂，该制剂含有：预糊化淀粉，其含有通式(1)所示的N-[4-[4-(1，2-苯并异噻唑-3-基)-1-哌嗪基]-(2R，3R)-2，3-四亚甲基-丁基]-(1’R，2’S，3’R，4’S)-2，3-双环[2，2，1]庚烷二酰亚胺·盐酸盐(lurasidone)作为活性成分；水溶性赋型剂；水溶性聚合物粘合剂，所述制剂具有恒定的溶出特性，即使其活性成分的含量发生变化时也是如此。

Drugs covered by this patent

lurasidone-hydrochloride (LURASIDONE HYDROCHLORIDE)

Patent Metadata

Patent number: CN102048734A
Jurisdiction: CN
Classification: —
Expires: 2011-05-11
Drug substance claim: No
Drug product claim: No
Assignee: Sumitomo Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.